stockrow
Sunday 8 November 2026
Export GRFS’s income statement to Excel — free account
Grifols, S.A.
GRFSHealthcare Drug Manufacturers General
Grifols, S.A.’s revenue for fiscal 2025 (year ended December 2025) was $8.5 billion, up 9.07% from fiscal 2024.
- Revenue
- +9.37%
- EPS
- +59.8%
- Free cash flow
- +4.11%
- Total debt
- −6.08%
Quarter to September 2026, against a year earlier
8.43
0.03
−0.35%
Follow GRFS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 5.80% | 0.00% | 5.33% | 6.28% |
+8 more TTM periods Free account |
|
| 2.28% | 0.00% | 2.09% | 2.04% | ||
ROIC |
4.76% | 0.00% | 4.51% | 4.74% | |
Return on Tangible Assets |
7.40% | 0.00% | 6.48% | 6.51% | |
Average Days of Receivables |
47.67 | 0.00 | 42.76 | 36.48 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.95 | |
Free Cash Flow |
750.37 | 739.71 | 602.42 | 645.83 | |
Capital Expenditures |
(503.59) | (506.66) | (568.18) | (538.74) | |
| Other line items | |||||
Cash ROIC |
3.59% | 3.52% | 2.82% | 3.15% | |
Accounts Receivable Turnover |
7.60 | 0.00 | 8.36 | 8.86 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 6.10 | |
Inventory Turnover |
1.39 | 0.00 | 1.39 | 1.40 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 65.80 | |
Days of Inventory on Hand |
264.53 | 0.00 | 273.94 | 257.89 | |
Tax Rate |
(0.18) | — | (0.19) | (0.19) | |
Research and Development Expense of Revenue |
5.41% | — | 5.64% | 5.66% | |
Selling, General and Administrative Expense of Revenue |
15.44% | — | 15.37% | 15.72% | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Interest Coverage |
2.08 | — | 2.00 | 1.99 | |
Operating CF/Net income |
2.36 | 0.00 | 2.45 | 2.60 | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.14 | 0.14 | |
Capex/Depreciation |
(0.99) | (1.00) | (1.11) | (1.06) | |
Revenue per Share |
0.00 | — | 0.00 | 12.51 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 1.74 | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.79) | |
Capex to Sales |
0.06 | 0.00 | 0.07 | 0.06 |
Columns are period end dates · fundamentals updated 5 Nov 2026